Cargando…
Non-coding RNAs as Genetic Biomarkers for the Diagnosis, Prognosis, Radiosensitivity, and Histopathologic Grade of Meningioma
Meningioma is considered the most common primary benign brain tumor. It originates from the arachnoid cells of the leptomeninges surrounding the brain. The mainstay treatment of meningiomas is microsurgical resection. Meningioma prognosis depends on tumor grade, location, and patient age. Recently,...
Autor principal: | Eraky, Akram M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9985895/ https://www.ncbi.nlm.nih.gov/pubmed/36883085 http://dx.doi.org/10.7759/cureus.34593 |
Ejemplares similares
-
Advances in Brain Metastases Diagnosis: Non-coding RNAs As Potential Biomarkers
por: Eraky, Akram M
Publicado: (2023) -
Radiological Biomarkers for Brain Metastases Prognosis: Quantitative Magnetic Resonance Imaging (MRI) Modalities As Non-invasive Biomarkers for the Effect of Radiotherapy
por: Eraky, Akram M
Publicado: (2023) -
Intraosseous Meningioma Along the Left Petrous Bone: A Rare Cause of Trigeminal Neuralgia
por: Lim, Phoebe, et al.
Publicado: (2022) -
Biomarkers (mRNAs and non-coding RNAs) for the diagnosis and prognosis of rheumatoid arthritis
por: Jiang, Yong, et al.
Publicado: (2023) -
Novel tumor necrosis factor-related long non-coding RNAs signature for risk stratification and prognosis in glioblastoma
por: Long, Shengrong, et al.
Publicado: (2023)